List of works - Fatima Amanat

A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)

scientific article published on 29 August 2020

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2

scientific article published on 17 April 2020

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

scientific article published on 17 December 2020

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

scientific article published on 31 July 2020

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

scientific article published on 26 June 2020

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

scientific article published on 30 July 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 18 March 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 12 May 2020

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

scientific article published on 01 September 2020

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

scientific article published on 4 April 2018

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.

scientific article

Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks

scientific article published on 14 August 2020

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.

scientific article

Antibody responses to influenza A(H1N1)pdm infection

scientific article published on 07 May 2020

Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients

scientific article published on 30 October 2020

Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit

scientific article published on 14 May 2020

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.

scientific article published on 11 April 2018

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

scientific article published on 05 March 2019

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

scientific article published on 23 December 2021

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

scientific article

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

scientific article published on 29 March 2017

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 06 July 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 17 October 2020

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

scientific article published on 15 September 2020

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin

scientific article published on 21 October 2019

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

scientific article

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

scientific article published on 20 June 2018

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

scientific article published on 25 September 2020

Distinct systems serology features in children, elderly and COVID patients

scientific article published on 18 May 2020

Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

scientific article published on 08 May 2020

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

scientific article

In Utero Vertical Transmission of Coronavirus Disease 2019 in a Severely Ill 29-week Preterm Infant

scientific article published on 01 July 2020

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

scientific article published on 21 January 2020

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

scientific article published on 18 August 2021

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

scientific article published on 17 September 2020

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

preprint published on 06 July 2020

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

scientific article published on 14 September 2020

Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein

scientific article published on 14 February 2020

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

scientific article published on 24 March 2020

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

scientific article published on 21 November 2020

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

scientific article published on 26 July 2020

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

scientific article published on 07 June 2017

Novel correlates of protection against pandemic H1N1 influenza A virus infection

scientific article published on 03 June 2019

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults

scientific article published on 12 July 2019

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

scientific article published on 15 August 2020

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

scientific article published on 03 November 2020

Robust and specific secretory IgA against SARS-CoV-2 detected in human milk

scientific article published on 26 October 2020

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

scientific article published on 28 October 2020

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

scientific article published on 02 November 2020

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

scientific article published on 24 December 2020

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

scientific article published on 01 June 2020

SARS-CoV-2 Vaccines: Status Report

scientific article published on 03 April 2020

SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation

scientific article published on 21 November 2020

SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19

scientific article published on 05 September 2020

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

scientific article published on 01 September 2020

Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak

scientific article published on 28 May 2020

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

scientific article published on 23 October 2020

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

scientific article published in November 2017

List of works by Fatima Amanat

A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

A serological assay to detect SARS-CoV-2 seroconversion in humans

A serological assay to detect SARS-CoV-2 seroconversion in humans

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.

Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.

Antibody responses to influenza A(H1N1)pdm infection

Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients

Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

Distinct systems serology features in children, elderly and COVID patients

Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

In Utero Vertical Transmission of Coronavirus Disease 2019 in a Severely Ill 29-week Preterm Infant

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

Novel correlates of protection against pandemic H1N1 influenza A virus infection

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

Robust and specific secretory IgA against SARS-CoV-2 detected in human milk

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

SARS-CoV-2 Vaccines: Status Report

SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation

SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans